Skip to main content
Aarti Industries Ltd logo

Aarti Industries Ltd — Investor Relations & Filings

Ticker · AARTIIND ISIN · INE769A01020 LEI · 335800JBE5SD89NHB831 BSE.NS Manufacturing
Open in API
Filings indexed 1,188 across all filing types
Latest filing 2026-02-02 Earnings Release
Country IN India
Listing BSE.NS AARTIIND

About Aarti Industries Ltd

https://www.aarti-industries.com/

Aarti Industries Ltd is a global manufacturer of specialty chemicals and pharmaceuticals, specializing in benzene-based derivatives. The company utilizes complex chemical processes such as chlorination, nitration, hydrogenation, and ammonolysis to produce a wide range of intermediates. Key products include nitrochlorobenzenes, dichlorobenzenes, phenylenediamines, and various sulfuric acid derivatives. These chemicals serve as critical inputs for the agrochemical, pharmaceutical, polymer, additive, surfactant, and pigment sectors. With a strong emphasis on research and development, the company operates integrated manufacturing complexes designed for process efficiency and environmental compliance. Its technical expertise allows for the production of high-purity chemicals used in crop protection, life-saving medicines, and advanced materials for industrial applications.

Recent filings

Filing Released Lang Actions
Press Release
Earnings Release Classification · 95% confidence The document is a press release announcing the unaudited financial results for the quarter and nine months ended December 31, 2025. It includes key financial highlights such as revenue, EBITDA, and profit after tax, along with commentary from the CEO and operational updates. The document is dated February 2, 2026, and is addressed to stock exchanges under Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to disclosure of material events. The content is typical of an Earnings Release (ER) as it provides initial quarterly financial results and key performance highlights without the full detailed financial statements or comprehensive analysis found in interim or annual reports. The document length (7231 characters) and the nature of the content support classification as an Earnings Release rather than a full Interim Report or Annual Report. Therefore, the appropriate classification is Earnings Release (ER). Q3 2026
2026-02-02 English
Outcome of Board Meeting
Regulatory Filings
2026-02-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges (BSE and NSE) informing them about the company's participation in an upcoming Analyst / Investor Meet. It references Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of an event (investor meeting) rather than a financial report, earnings release, or detailed presentation. The document length is only 1433 characters, indicating it is a brief notice. Therefore, it fits best under the category of Investor Presentation (IP) updates or announcements. However, since it is only an intimation of attendance at an investor meet and not the presentation itself, it is more appropriate to classify it as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory announcements and disclosures that do not fit other categories. Confidence is high due to clear regulatory reference and document content.
2026-01-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 85% confidence The document is a notification to stock exchanges about a scheduled quarterly earnings conference call for discussing the company's financial results for the quarter and nine months ended December 31, 2025. It includes details about the call timing, dial-in numbers, and participants. There is no actual financial data or detailed financial report included, only an announcement of the conference call event. This fits the definition of a Call Transcript (CT) announcement, but since it is only the invitation and scheduling notice, it is not the transcript itself. However, the closest fitting category is Call Transcript (CT) as it relates to the earnings call. The document is not a full earnings release (ER) because it does not contain financial highlights or results, only the call scheduling. Therefore, the best classification is CT with moderate to high confidence.
2026-01-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges informing them about upcoming analyst and investor meetings. It references Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to disclosure obligations. The content is an announcement of scheduled investor interactions, not a financial report, earnings release, or detailed presentation. The document length is only 1507 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-01-27 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-01-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.